145 related articles for article (PubMed ID: 10365923)
1. The antiangiogenic agents TNP-470 and 2-methoxyestradiol inhibit the growth of angiosarcoma in mice.
Arbiser JL; Panigrathy D; Klauber N; Rupnick M; Flynn E; Udagawa T; D'Amato RJ
J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):925-9. PubMed ID: 10365923
[TBL] [Abstract][Full Text] [Related]
2. Treatment of murine angiosarcoma with etoposide, TNP-470 and prednisolone.
Ma G; Masuzawa M; Hamada Y; Haraguchi F; Tamauchi H; Sakurai Y; Fujimura T; Katsuoka K
J Dermatol Sci; 2000 Nov; 24(2):126-33. PubMed ID: 11064248
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis inhibition with TNP-470, 2-methoxyestradiol, and paclitaxel in experimental pancreatic carcinoma.
Ryschich E; Werner J; Gebhard MM; Klar E; Schmidt J
Pancreas; 2003 Mar; 26(2):166-72. PubMed ID: 12604915
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice.
Beecken WD; Fernandez A; Panigrahy D; Achilles EG; Kisker O; Flynn E; Joussen AM; Folkman J; Shing Y
Urology; 2000 Sep; 56(3):521-6. PubMed ID: 10962337
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of the antiangiogenic agent TNP-470 on establishment and growth of hematogenous metastasis of human pancreatic carcinoma in SCID beige mice in vivo.
Kawarada Y; Ishikura H; Kishimoto T; Saito K; Takahashi T; Kato H; Yoshiki T
Pancreas; 1997 Oct; 15(3):251-7. PubMed ID: 9336788
[TBL] [Abstract][Full Text] [Related]
6. Contribution of angiogenesis to the progression of colon cancer: possible inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and hepatic metastasis.
Takatsuka S; Yamada N; Sawada T; Ogawa Y; Maeda K; Ohira M; Ishikawa T; Nishino H; Seki S; Hirakawa-YS Chung K
Int J Oncol; 2000 Aug; 17(2):253-8. PubMed ID: 10891532
[TBL] [Abstract][Full Text] [Related]
7. TNP-470 antiangiogenic therapy for advanced murine neuroblastoma.
Nagabuchi E; VanderKolk WE; Une Y; Ziegler MM
J Pediatr Surg; 1997 Feb; 32(2):287-93. PubMed ID: 9044139
[TBL] [Abstract][Full Text] [Related]
8. Effects of angiogenesis inhibitor TNP-470 on tamoxifen-stimulated MCF-7 breast tumors in nude mice.
Takei H; Lee ES; Cisneros A; Jordan VC
Cancer Lett; 2000 Jul; 155(2):129-35. PubMed ID: 10822127
[TBL] [Abstract][Full Text] [Related]
9. The effect of the anti-angiogenic agent TNP-470 on tumor growth and vascularity in low passaged xenografts of human gliomas in nude mice.
Bernsen HJ; Rijken PF; Peters H; Bakker H; van der Kogel AJ
J Neurooncol; 1998 May; 38(1):51-7. PubMed ID: 9540057
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of the anti-angiogenesis drug TNP-470.
Gervaz P; Fontolliet C
Int J Exp Pathol; 1998 Dec; 79(6):359-62. PubMed ID: 10319017
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470.
Yazaki T; Takamiya Y; Costello PC; Mineta T; Menon AG; Rabkin SD; Martuza RL
J Neurooncol; 1995; 23(1):23-9. PubMed ID: 7542695
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of liver metastasis of human pancreatic carcinoma by angiogenesis inhibitor TNP-470 in combination with cisplatin.
Shishido T; Yasoshima T; Denno R; Mukaiya M; Sato N; Hirata K
Jpn J Cancer Res; 1998 Sep; 89(9):963-9. PubMed ID: 9818033
[TBL] [Abstract][Full Text] [Related]
13. TNP-470 (AGM-1470): mechanisms of action and early clinical development.
Castronovo V; Belotti D
Eur J Cancer; 1996 Dec; 32A(14):2520-7. PubMed ID: 9059342
[No Abstract] [Full Text] [Related]
14. Angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth.
Hotz HG; Reber HA; Hotz B; Sanghavi PC; Yu T; Foitzik T; Buhr HJ; Hines OJ
J Gastrointest Surg; 2001; 5(2):131-8. PubMed ID: 11331474
[TBL] [Abstract][Full Text] [Related]
15. Effect of angiogenesis inhibitor TNP-470 on the growth, blood flow, and microvessel density in xenografts of human uterine carcinosarcoma in nude mice.
Emoto M; Ishiguro M; Iwasaki H; Kikuchi M; Kawarabayashi T
Gynecol Oncol; 2003 Apr; 89(1):88-94. PubMed ID: 12694659
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic treatment for peritoneal dissemination of pancreas adenocarcinoma: a study using TNP-470.
Kato H; Ishikura H; Kawarada Y; Furuya M; Kondo S; Kato H; Yoshiki T
Jpn J Cancer Res; 2001 Jan; 92(1):67-73. PubMed ID: 11173546
[TBL] [Abstract][Full Text] [Related]
17. TNP-470 promotes initial vascular sprouting in xenograft tumors.
Huang J; Frischer JS; New T; Kim ES; Serur A; Lee A; Kadenhe-Chiwishe A; Pollyea DA; Yokoi A; Holash J; Yancopoulos GD; Kandel JJ; Yamashiro DJ
Mol Cancer Ther; 2004 Mar; 3(3):335-43. PubMed ID: 15026554
[TBL] [Abstract][Full Text] [Related]
18. Carcinosarcoma-induced endothelial cells tube formation through KDR/Flk-1 is blocked by TNP-470.
Miura S; Emoto M; Matsuo Y; Kawarabayashi T; Saku K
Cancer Lett; 2004 Jan; 203(1):45-50. PubMed ID: 14670616
[TBL] [Abstract][Full Text] [Related]
19. Effect of angiogenesis inhibitor TNP-470 on the progression of human gastric cancer xenotransplanted into nude mice.
Kanai T; Konno H; Tanaka T; Matsumoto K; Baba M; Nakamura S; Baba S
Int J Cancer; 1997 May; 71(5):838-41. PubMed ID: 9180154
[TBL] [Abstract][Full Text] [Related]
20. Clinical trials of antiangiogenic agents.
Twardowski P; Gradishar WJ
Curr Opin Oncol; 1997 Nov; 9(6):584-9. PubMed ID: 9370081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
